Results of radiation therapy combined with neoadjuvant hormonal therapy for stage III prostate cancer: Comparison of two different definitions of PSA failure

International Journal of Clinical Oncology

Volumn 11, Issue 5, 2006, Pages 396-402

  Mitsumori, Michihide ^a   Sasaki, Yoshihide ^a   Mizowaki, Takashi ^a   Takayama, Kenji ^a   Nagata, Yasushi ^a   Hiraoka, Masahiro ^a   Negoro, Yoshiharu ^b   Sasai, Keisuke ^c   Kinoshita, Hidefumi ^d   Kamoto, Toshiyuki ^a   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b FUKUI PREFECTURAL HOSPITAL   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Neoadjuvant hormonal therapy; Prostate cancer; PSA failure; Radiation therapy

Indexed keywords

ANTIANDROGEN; FLUTAMIDE; GONADORELIN; GOSERELIN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; AGED; ANUS DISEASE; ARTICLE; BLEEDING; BOUGIE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DYSURIA; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HEMATURIA; HORMONAL THERAPY; HUMAN; MEDICAL SOCIETY; OVERALL SURVIVAL; POLLAKISURIA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; SURVIVAL RATE; TREATMENT OUTCOME; URETHRA STENOSIS;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FLUTAMIDE; GONADOTROPIN-RELEASING HORMONE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750293856     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0600-7     Document Type: Article

References (36)

1. National Cancer (2003) Cancer statistics in Japan 2003
2. PC Walsh 1997 Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group J Urol 158 1623 1624
3. R Lundgren O Nordle K Josefsson 1995 Immediate estrogen or estramustine phosphate therapy versus deferred endocrine treatment in nonmetastatic prostate cancer: a randomized multicenter study with 15 years of followup. The South Sweden Prostate Cancer Study Group J Urol 153 1580 1586
4. G Aus J Adolfsson C Selli 2002 Treatment of patients with clinical T3 prostate cancer Scand J Urol Nephrol 36 28 33
5. MV Pilepich JM Krall M Al-Sarraf 1995 Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group Urology 45 616 623
6. M Bolla D Gonzalez P Warde 1997 Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 295 300
7. MV Pilepich K Winter MJ John 2001 Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 50 1243 1252
8. WU Shipley JD Lu MV Pilepich 2002 Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10 Int J Radiat Oncol Biol Phys 54 1302 1310
9. MM Oken RH Creech DC Tormey 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649 655
10. Y Nagata K Okajima R Murata 1996 Development of an integrated radiotherapy network system Int J Radiat Oncol Biol Phys 34 1105 1111
11. S Zhu T Mizowaki Y Nagata 2005 Comparison of three radiotherapy treatment planning protocols of definitive external-beam radiation for localized prostate cancer Int J Clin Oncol 10 398 404
12. JD Cox J Stetz TF Pajak 1995 Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1341 1346
13. American Society for Therapeutic Radiology and Oncology consensus panel 1997 Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel Int J Radiat Oncol Biol Phys 37 1035 1041
14. JJ Coen CS Chung WU Shipley 2003 Influence of follow-up bias on PSA failure after external beam radiotherapy for localized prostate cancer: results from a 10-year cohort analysis Int J Radiat Oncol Biol Phys 57 621 628
15. AV D'Amico R Whittington I Kaplan 1997 Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of >4-20 ng/ml Int J Radiat Oncol Biol Phys 37 1053 1058
16. D Keyser PA Kupelian CD Zippe 1997 Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery? Int J Radiat Oncol Biol Phys 38 723 729
17. P Kupelian J Katcher H Levin 1997 External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores Cancer J Sci Am 3 78 87
18. K Sato N Tsuchiya T Habuchi 2003 Total cystoprostatectomy in the treatment of locally advanced prostate carcinoma Aktuelle Urol 34 259 261
19. H Kanamaru Y Arai H Akino 1999 Long-term treatment results of elderly patients with prostate cancer in Japan: an analysis of prognostic factors Jpn J Clin Oncol 29 151 155
20. GS Gerber RA Thisted GW Chodak 1997 Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis Eur Urol 32 385 390
21. D van den Ouden WC Hop FH Schroder 1998 Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy J Urol 160 1392 1397
22. K Akakura S Isaka S Akimoto 1999 Long-term results of a randomized trial for the treatment of stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities Urology 54 313 318
23. R Valicenti J Lu M Pilepich 2000 Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials J Clin Oncol 18 2740 2746
24. PA Kupelian M Elshaikh CA Reddy 2002 Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy J Clin Oncol 20 3376 3385
25. A Pollack GK Zagars G Starkschal 2002 Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 1097 1105
26. J Laverdiere A Nabid LD De Bedoya 2004 The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical failure when administered with radiation therapy for T2-T3 prostate cancer J Urol 171 1137 1140
27. J Laverdiere JL Gomez L Cusan 1997 Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer Int J Radiat Oncol Biol Phys 37 247 252
28. JD Forman R Kumar G Haas 1995 Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation Cancer Invest 13 8 15
29. M Liu T Pickles A Agranovich 2004 Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy Int J Radiat Oncol Biol Phys 58 9 67
30. G Sanguineti S Agostinelli F Foppiano 2002 Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma Br J Cancer 86 1843 1847
31. RK Valicenti K Winter JD Cox 2003 RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity? Int J Radiat Oncol Biol Phys 57 614 620
32. MV Pilepich R Caplan RW Byhardt 1997 Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31 J Clin Oncol 15 1013 1021
33. M Roach 3rd J Lu MV Pilepich 2000 Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials Int J Radiat Oncol Biol Phys 47 617 627
34. MJ Zelefsky Z Fuks M Hunt 2001 High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 876 881
35. M Roach 3rd M DeSilvio C Lawton 2003 Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 1904 1911
36. B Movsas AL Hanlon W Pinover 1998 Is there an increased risk of second primaries following prostate irradiation? Int J Radiat Oncol Biol Phys 41 251 255